New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Dr. Reddy’s Recalls Cholesterol Drug for Quality Concerns

The drug is prescribed for patients with cardiovascular diseases and risk or heart attack.

A recent LiveMint article discusses the recall of Dr. Reddy’s cholesterol-lowering drug Atorvastatin, which is intended for adults and children over ten. The company voluntarily recalled 2,980 bottles of Atorvastatin Calcium tablets in the United States due to “failed impurities degradation specifications.” The 500-count bottles were manufactured at Dr. Reddy’s plant in Bachupally, India and later shipped to the U.S. The recall is classified as Class III, which means use of the recalled product is not likely to cause adverse health consequences.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts